How did pharmaceutical companies and lawmakers respond to Trump’s drug-pricing statements?
Pharmaceutical companies reacted to President Trump’s drug‑pricing campaign with a mix of public pushback, legal resistance to other federal price controls, and selectively cooperative deals that trad...